Ballentine Partners, LLC Maravai Lifesciences Holdings, Inc. Transaction History
Ballentine Partners, LLC
- $7.1 Billion
- Q3 2025
A detailed history of Ballentine Partners, LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Ballentine Partners, LLC holds 12,826 shares of MRVI stock, worth $46,686. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,826Holding current value
$46,686% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MRVI
# of Institutions
182Shares Held
132MCall Options Held
688KPut Options Held
11.6K-
Gtcr LLC20.2MShares$73.3 Million6.38% of portfolio
-
12 West Capital Management LP New York, NY12.5MShares$45.6 Million4.42% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$35.4 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$30.4 Million1.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.13MShares$25.9 Million0.0% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $479M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...